Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Pacira BioSciences, Inc. (PCRX)

Healthcare Drug Manufacturers - Specialty & Generic

26.40 $

-2.1% vs. previous close

Closing price · As of: 31. Jul 2026

Pacira BioSciences, Inc. (PCRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 1,265 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow

Annual Quarterly

All figures in millions of USD.

Balance Sheet PCRX
Tick rows to compare them in a chart (up to 4)	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	326	390	391	628	689	831	1,275	2,075	1,681	1,574	1,554	1,265
Current Assets	214	253	243	391	478	409	652	866	498	510	745	548
Cash	158	159	36	54	133	78	100	586	104	153	277	159
Cash & Short-Term Investments	158	159	173	311	383	292	522	656	289	279	485	238
Receivables	22	26	30	32	38	48	53	96	98	106	113	124
Inventory	29	62	31	41	49	58	65	99	96	104	125	153
Property, Plant & Equipment	61	90	101	107	109	105	137	265	254	–	–	–
Goodwill	24	31	47	55	62	100	100	145	163	163	0.0	20
Intangible Assets	0.4	0.1	47	55	–	104	97	624	541	483	426	368
Total Liabilities	155	171	172	349	368	476	655	1,345	906	704	775	572
Current Liabilities	140	152	45	56	61	108	253	521	148	97	310	121
Short-Term Debt	103	104	109	0.3	0.3	4.9	157	383	43	17	211	9.8
Accounts Payable	6.8	8.7	7.5	15	14	13	10	11	15	16	19	15
Long-Term Debt	0.0	0.0	109	276	291	306	313	675	656	514	384	372
Shareholders' Equity	171	218	219	279	321	355	620	730	775	870	778	693
Retained Earnings	-310	-308	-346	-389	-388	-399	-254	-212	-149	-107	-206	-199
Shares Outstanding	35	41	37	40	41	42	44	46	47	52	46	45

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Cookie settings